JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scarborough, R. M.
Right arrow Articles by Charo, I. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scarborough, R. M.
Right arrow Articles by Charo, I. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 15, 9359-9362, 05, 1991

Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri

RM Scarborough, JW Rose, MA Hsu, DR Phillips, VA Fried, AM Campbell, L Nannizzi and IF Charo
COR Therapeutics, Inc., South San Francisco, California 94080.

Sixty-two snake venoms were screened to identify those which specifically inhibit the adhesive protein binding function of the glycoprotein (GP) IIb-IIIa complex, the receptor-mediating platelet aggregation. Although 52 of these venoms inhibited GPIIb-IIIa, only one of these, from the southeastern pigmy rattlesnake, Sistrurus m. barbouri, was specific for GPIIb-IIIa versus other integrins. The peptide responsible for this activity, termed barbourin, was sequenced and found to be highly homologous to other peptides of the viper venom GPIIb-IIIa antagonist family but was the first member which did not contain the Arg-Gly-Asp (RGD) amino acid sequence, believed to be required for inhibition of receptor function. Instead, barbourin contains the sequence, Lys-Gly-Asp (KGD). The conservative Lys for Arg substitution appears to be the sole structural feature which imparts integrin specificity to barbourin, since venom peptide analogs with Lys substitutions were also specific for GPIIb-IIIa. Thus, barbourin represents a new structural model useful for designing potent and GPIIb- IIIa-specific compounds that may have therapeutic value as platelet aggregation inhibitors.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Sumathipala, C. Xu, J. Seago, A. P. Mould, M. J. Humphries, S. E. Craig, Y. Patel, E. S. Wijelath, M. Sobel, and S. Rahman
The "Linker" Region (Amino Acids 38-47) of the Disintegrin Elegantin Is a Novel Inhibitory Domain of Integrin {alpha}5beta1-Dependent Cell Adhesion on Fibronectin: EVIDENCE FOR THE NEGATIVE REGULATION OF FIBRONECTIN SYNERGY SITE BIOLOGICAL ACTIVITY
J. Biol. Chem., December 8, 2006; 281(49): 37686 - 37696.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
R. R. Hantgan, M. C. Stahle, J. H. Connor, D. A. Horita, M. Rocco, M. A. McLane, S. Yakovlev, and L. Medved
Integrin {alpha}IIbbeta3:ligand interactions are linked to binding-site remodeling.
Protein Sci., August 1, 2006; 15(8): 1893 - 1906.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Calvete
Structures of Integrin Domains and Concerted Conformational Changes in the Bidirectional Signaling Mechanism of {alpha}IIb{beta}3
Experimental Biology and Medicine, September 1, 2004; 229(8): 732 - 744.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Nannizzi-Alaimo, V. L. Alves, and D. R. Phillips
Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation
Circulation, March 4, 2003; 107(8): 1123 - 1128.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
M. P. Moreno-Murciano, D. Monleon, J. J. Calvete, B. Celda, and C. Marcinkiewicz
Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa
Protein Sci., February 1, 2003; 12(2): 366 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Mans, A. I. Louw, and A. W. H. Neitz
Savignygrin, a Platelet Aggregation Inhibitor from the Soft Tick Ornithodoros savignyi, Presents the RGD Integrin Recognition Motif on the Kunitz-BPTI Fold
J. Biol. Chem., June 7, 2002; 277(24): 21371 - 21378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Nykvist, K. Tasanen, T. Viitasalo, J. Kapyla, J. Jokinen, L. Bruckner-Tuderman, and J. Heino
The Cell Adhesion Domain of Type XVII Collagen Promotes Integrin-mediated Cell Spreading by a Novel Mechanism
J. Biol. Chem., October 12, 2001; 276(42): 38673 - 38679.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. J. Fintel
From bench to bedside: GP IIb-IIIa inhibitors
Neurology, September 1, 2001; 57(90002): S12 - 19.
[Abstract] [Full Text]


Home page
Protein Sci.Home page
R. R. Hantgan, M. Rocco, C. Nagaswami, and J. W. Weisel
Binding of a fibrinogen mimetic stabilizes integrin {alpha}IIb{beta}3's open conformation
Protein Sci., August 1, 2001; 10(8): 1614 - 1626.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Wierzbicka-Patynowski, S. Niewiarowski, C. Marcinkiewicz, J. J. Calvete, M. M. Marcinkiewicz, and M. A. McLane
Structural Requirements of Echistatin for the Recognition of alpha vbeta 3 and alpha 5beta 1 Integrins
J. Biol. Chem., December 31, 1999; 274(53): 37809 - 37814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. Cierniewski, T. Byzova, M. Papierak, T. A. Haas, J. Niewiarowska, L. Zhang, M. Cieslak, and E. F. Plow
Peptide Ligands Can Bind to Distinct Sites in Integrin alpha IIbbeta 3 and Elicit Different Functional Responses
J. Biol. Chem., June 11, 1999; 274(24): 16923 - 16932.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Bates and J. I. Weitz
Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin
Cardiovasc Res, February 1, 1999; 41(2): 418 - 432.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. Pabla, A. S. Weyrich, D. A. Dixon, P. F. Bray, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman
Integrin-dependent Control of Translation: Engagement of Integrin alpha IIbbeta 3 Regulates Synthesis of Proteins in Activated Human Platelets
J. Cell Biol., January 11, 1999; 144(1): 175 - 184.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Marcinkiewicz, S. Vijay-Kumar, M. A. McLane, and S. Niewiarowski
Significance of RGD Loop and C-Terminal Domain of Echistatin for Recognition of alpha IIbbeta 3 and alpha vbeta 3 Integrins and Expression of Ligand-Induced Binding Site
Blood, August 15, 1997; 90(4): 1565 - 1575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-G. Jia, X.-M. Wang, J. D. Shannon, J. B. Bjarnason, and J. W. Fox
Function of Disintegrin-like/Cysteine-rich Domains of Atrolysin A. INHIBITION OF PLATELET AGGREGATION BY RECOMBINANT PROTEIN AND PEPTIDE ANTAGONISTS
J. Biol. Chem., May 16, 1997; 272(20): 13094 - 13102.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Syed, P. D. Schuyler, M. Kulczycky, and W. P. Sheffield
Potent Antithrombin Activity and Delayed Clearance From the Circulation Characterize Recombinant Hirudin Genetically Fused to Albumin
Blood, May 1, 1997; 89(9): 3243 - 3252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Katada, Y. Hayashi, Y. Sato, M. Muramatsu, Y. Takiguchi, T. Harada, T. Fujiyoshi, and I. Uno
A Novel Peptide Motif for Platelet Fibrinogen Receptor Recognition
J. Biol. Chem., March 21, 1997; 272(12): 7720 - 7726.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Kunicki, D. S. Annis, and B. Felding-Habermann
Molecular Determinants of Arg-Gly-Asp Ligand Specificity for beta 3 Integrins
J. Biol. Chem., February 14, 1997; 272(7): 4103 - 4107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wang, L. B. Coons, D. B. Taylor, S. E. Stevens Jr., and T. K. Gartner
Variabilin, a Novel RGD-containing Antagonist of Glycoprotein IIb-IIIa and Platelet Aggregation Inhibitor from the Hard Tick Dermacentor variabilis
J. Biol. Chem., July 26, 1996; 271(30): 17785 - 17790.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Mateu, M. L. Valero, D. Andreu, and E. Domingo
Systematic Replacement of Amino Acid Residues within an Arg-Gly-Asp-containing Loop of Foot-and-Mouth Disease Virus and Effect on Cell Recognition
J. Biol. Chem., May 31, 1996; 271(22): 12814 - 12819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Suehiro, J. W. Smith, and E. F. Plow
The Ligand Recognition Specificity of beta(3) Integrins
J. Biol. Chem., April 26, 1996; 271(17): 10365 - 10371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Loftus, C. E. Halloran, M. H. Ginsberg, L. P. Feigen, J. A. Zablocki, and J. W. Smith
The Amino-terminal One-third of alpha[IMAGE] Defines the Ligand Recognition Specificity of Integrin alpha[IMAGE]beta(3)
J. Biol. Chem., January 26, 1996; 271(4): 2033 - 2039.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Lu, S. Rahman, V. V. Kakkar, and K. S. Authi
Substitutions of Proline 42 to Alanine and Methionine 46 to Asparagine around the RGD Domain of the Neurotoxin Dendroaspin Alter Its Preferential Antagonism to That Resembling the Disintegrin Elegantin
J. Biol. Chem., January 5, 1996; 271(1): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Kunicki, K. R. Ely, T. C. Kunicki, Y. Tomiyama, and D. S. Annis
The Exchange of Arg-Gly-Asp (RGD) and Arg-Tyr-Asp (RYD) Binding Sequences in a Recombinant Murine Fab Fragment Specific for the Integrin [IMAGE][IMAGE][IMAGE][IMAGE] Does Not Alter Integrin Recognition
J. Biol. Chem., July 14, 1995; 270(28): 16660 - 16665.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Lefkovits, E. F. Plow, and E. J. Topol
Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
N. Engl. J. Med., June 8, 1995; 332(23): 1553 - 1559.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Hu, J. R. Hoyer, and J. W. Smith
Ca[IMAGE]Suppresses Cell Adhesion to Osteopontin by Attenuating Binding Affinity for Integrin [IMAGE][IMAGE][IMAGE][IMAGE]
J. Biol. Chem., April 28, 1995; 270(17): 9917 - 9925.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.